S

Shashikala

Active Director Director DIN 09729542
DIN 09729542 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Shashikala

Data last updated:

Shashikala is a Director at Dr. Dalavai's Laboratories Private Limited (since 2022). The company operates in Pharma. Dr. Dalavai's Laboratories Private Limited reported revenue of ₹6.29 Cr (FY 2025).

DIN 09729542
Primary Designation Director
Industry Pharma
First Appointment 02 Sep 2022
Oldest Company Age 4 yrs
Largest company Dr. Dalavai's Laboratories Private Limited · ₹6.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Sep 20222022₹6.29 Cr (FY 2025)Active

Board colleagues of Shashikala

NameDINCompanyDesignation
Ramesh Dalavai09729541Dr. Dalavai's Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr. Dalavai's Laboratories Private Limited
Premium access

Shareholding and investment profile for Shashikala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashikala

Shashikala currently holds 1 directorship: Dr. Dalavai's Laboratories Private Limited (Director, since 02 Sep 2022, revenue ₹6.29 Cr (FY 2025)).

Shashikala was first appointed on 02 Sep 2022 as Director at Dr. Dalavai's Laboratories Private Limited.

The current boards of Shashikala's companies include Ramesh Dalavai (Dr. Dalavai's Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available